Let the board chat. It’s helpful and therapeutic. Through months of discussion the board has uncovered and produced helpful insight for Amarin and the legal team.
I know it’s frustrating. It’s been this way for about two years. It seems to be the price we are all paying as investors and supporters of Amarin-Vascepa. It’s our “cross” so to speak.
I think that we are close to concluding this journey or story. So, let the board work through it.
News 
Market Data 
Discover 
AI
